Journal
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Volume 31, Issue 11, Pages 2905-2910Publisher
SPRINGER
DOI: 10.1007/s10096-012-1675-x
Keywords
-
Categories
Funding
- Portuguese Foundation for Science and Technology (FCT) [SFRH/BPD/47693/2008, SFRH/BPD/20987/2004, SFRH/BPD/72632/2010]
- Fundação para a Ciência e a Tecnologia [SFRH/BPD/20987/2004, SFRH/BPD/47693/2008] Funding Source: FCT
Ask authors/readers for more resources
Infective endocarditis despite advances in diagnosis remains a common cause of hospitalization, with high morbidity and mortality rates. Through literature review it is possible to conclude that polymicrobial endocarditis occurs mainly in intravenous drug abusers with predominance in the right side of the heart, often with tricuspid valve involvement. This fact can be associated with the type of drug used by the patients; therefore, knowledge of the patient's history is critical for adjustment of the therapy. It is also important to emphasize that the most common combinations of organisms in polymicrobial infective endocarditis are: Staphylococcus aureus, Streptococcus pneumonia and Pseudomonas aeruginosa, as well as mixed cultures of Candida spp. and bacteria. A better understanding of the epidemiology and associated risk factors are required in order to develop an efficient therapy, although PE studies are difficult to perform due to the rarity of cases and lack of prospective cohorts.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available